Colin Miller

Contributing Writer

5 Years of Experience

About

Colin Miller is a staff writer and medtech analyst. Colin focuses on emerging and disruptive medical device technologies within vast therapeutic areas such as women’s health, wound care, neurovascular, critical care, surgical robotics and cardiovascular. Colin attended McGill University in Montreal and graduated from the University of Minnesota.

Articles from Colin Miller:

Investors & Dealmaking

The Digest June 2026

In this month's news, FDA clearances for several imaging technologies, Resmed expands into sleep medicine by buying Noctrix Health, TAP pilot progress, and more.

Read Article